Skip to main content

Single-Tenant Office Medical

Neuragenex | New 20-Yr. Absolute NNN

2780 W Main St, St. Charles (Chicago MSA), IL 60175

Listing Price: $6,401,492

Cap Rate
7.00%
Tenant Name
Neuragenex
Years Remaining On Lease
20.2
Guarantor
Corporate Guarantee
Rentable SF
3,369
Lease Type
Triple Net (NNN)
Rent Per Square Feet
$134.15

Investment Overview

Marcus & Millichap is pleased to present the Neuragenex in St Charles, IL.

Investment Highlights

  • 20-Year Absolute NNN Lease with 2% Annual Increases Providing a Hedge Against Inflation
  • Corporate Guaranty from Neuragenex, LLC and Personal Guaranty from its CEO
  • 5 Units Open with Growing Patient Counts and 37 Additional Sites in Development Opening this Year
  • Neuragenex Secured $2.6 Billion in 2022 to Fund Growth and Open 750 Primary Care-Based Pain Treatment Centers Over the Next 5 Years
  • Nation's Fastest Growing Pain Treatment Practice Through Non-Pharmaceutical, Non-Surgical, Non-Invasive Pain Treatment Program
  • Serving Over 104,000 Residents in the Growing West Suburban Chicago MSA
  • Surrounded by Affluent Communities, Average Household Income Exceeds $140,000 within 3 and 5 Miles
  • Highly Visible Along Major Commercial Artery with 35,000 Cars/Day, Direct Access to Downtown Chicago

Exclusively Listed By

Broker of Record

  • Steven D. Weinstock

    Senior Vice President/Regional Manager

    (630) 570-2200

    License(s) IL: 471.011175

    Illinois

Financing By

Single-Tenant Office Medical

Neuragenex | New 20-Yr. Absolute NNN

Listing Price: $6,401,492

Cap Rate
7.00%
Tenant Name
Neuragenex
Years Remaining On Lease
20.2
Guarantor
Corporate Guarantee
Rentable SF
3,369
Lease Type
Triple Net (NNN)
Rent Per Square Feet
$134.15

Investment Highlights

  • 20-Year Absolute NNN Lease with 2% Annual Increases Providing a Hedge Against Inflation
  • Corporate Guaranty from Neuragenex, LLC and Personal Guaranty from its CEO
  • 5 Units Open with Growing Patient Counts and 37 Additional Sites in Development Opening this Year
  • Neuragenex Secured $2.6 Billion in 2022 to Fund Growth and Open 750 Primary Care-Based Pain Treatment Centers Over the Next 5 Years
  • Nation's Fastest Growing Pain Treatment Practice Through Non-Pharmaceutical, Non-Surgical, Non-Invasive Pain Treatment Program
  • Serving Over 104,000 Residents in the Growing West Suburban Chicago MSA
  • Surrounded by Affluent Communities, Average Household Income Exceeds $140,000 within 3 and 5 Miles
  • Highly Visible Along Major Commercial Artery with 35,000 Cars/Day, Direct Access to Downtown Chicago

Investment Overview

Marcus & Millichap is pleased to present the Neuragenex in St Charles, IL.

Exclusively Listed By

Broker of Record

  • Steven D. Weinstock

    Senior Vice President/Regional Manager

    (630) 570-2200

    License(s): IL: 471.011175

    Illinois

Financing By

MM Texture Background
MM Textured Background Lower